Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Seidl

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Scientific Reports|June 6, 2019
Assessment of <sup>213</sup>Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-<sup>13</sup>C]pyruvate and [<sup>18</sup>F]FDGBenedikt Feuerecker, Michael Michalik, Christian Hundshammer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2010
177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213BiChristof Seidl, Christine Zöckler, Roswitha Beck, et al.
Scientific Reports|March 19, 2021
Diverse metabolic response of cancer cells treated with a <sup>213</sup>Bi-anti-EGFR-immunoconjugateBenedikt Feuerecker, Philipp Biechl, Christof Seidl, et al.
Nuclear Medicine and Biology|March 3, 2012
High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumChristian Rauch, Christof Seidl, Martin Schlapschy, et al.
Cancer Biology & Therapy|September 8, 2012
Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivoBenedikt Feuerecker, Sabine Pirsig, Christof Seidl, et al.
EJNMMI Research|August 10, 2018
Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeuticsJakub Šimeček, Petr Hermann, Christof Seidl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2009
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatmentSebastian A Müller, Korbinian Holzapfel, Christof Seidl, et al.
Investigational New Drugs|January 14, 2009
Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cellsChristof Seidl, Matthias Port, Christos Apostolidis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 7, 2008
Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3Korbinian Holzapfel, Sebastian A Müller, Christof Seidl, et al.
American Journal of Cancer Research|July 16, 2015
Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cellsHans-Richard Demel, Benedikt Feuerecker, Guido Piontek, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Scientific Reports|June 6, 2019
Assessment of <sup>213</sup>Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-<sup>13</sup>C]pyruvate and [<sup>18</sup>F]FDGBenedikt Feuerecker, Michael Michalik, Christian Hundshammer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2010
177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213BiChristof Seidl, Christine Zöckler, Roswitha Beck, et al.
Scientific Reports|March 19, 2021
Diverse metabolic response of cancer cells treated with a <sup>213</sup>Bi-anti-EGFR-immunoconjugateBenedikt Feuerecker, Philipp Biechl, Christof Seidl, et al.
Nuclear Medicine and Biology|March 3, 2012
High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumChristian Rauch, Christof Seidl, Martin Schlapschy, et al.
Cancer Biology & Therapy|September 8, 2012
Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivoBenedikt Feuerecker, Sabine Pirsig, Christof Seidl, et al.
EJNMMI Research|August 10, 2018
Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeuticsJakub Šimeček, Petr Hermann, Christof Seidl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2009
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatmentSebastian A Müller, Korbinian Holzapfel, Christof Seidl, et al.
Investigational New Drugs|January 14, 2009
Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cellsChristof Seidl, Matthias Port, Christos Apostolidis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 7, 2008
Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3Korbinian Holzapfel, Sebastian A Müller, Christof Seidl, et al.
American Journal of Cancer Research|July 16, 2015
Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cellsHans-Richard Demel, Benedikt Feuerecker, Guido Piontek, et al.
Pageof 5